Window of opportunity: Estrogen as a treatment for ischemic stroke

Brain Research

Volumn 1514, Issue , 2013, Pages 83-90

  Liu, Ran ^a   Yang, Shao Hua ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Estrogen; Ischemia; Neuroprotection; Neurovascular unit; Recombinant tissue plasminogen activator; Stroke

Indexed keywords

ALTEPLASE; BLOOD CLOTTING FACTOR 7; CONJUGATED ESTROGEN; ESTROGEN; ORAL CONTRACEPTIVE AGENT; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN;

AGING; ARTERY OCCLUSION; ATHEROSCLEROTIC PLAQUE; BASIC RESEARCH; BLOOD CLOT LYSIS; BLOOD CLOTTING; BRAIN ISCHEMIA; BRAIN PROTECTION; CEREBROVASCULAR ACCIDENT; DEEP VEIN THROMBOSIS; DIABETIC PATIENT; DISEASE COURSE; ESTROGEN THERAPY; FIBRINOLYSIS; HEART INFARCTION; HUMAN; MULTIINFARCT DEMENTIA; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SEX DIFFERENCE; VENOUS THROMBOEMBOLISM;

ANIMALS; BRAIN ISCHEMIA; CLINICAL TRIALS AS TOPIC; DRUG THERAPY, COMBINATION; ESTROGENS; FEMALE; HUMANS; MALE; NEUROPROTECTIVE AGENTS; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84878513685     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.01.023     Document Type: Review

References (83)

1. N.J. Alkayed, I. Harukuni, A.S. Kimes, E.D. London, R.J. Traystman, and P.D. Hurn Gender-linked brain injury in experimental stroke Stroke 29 1998 159 165 discussion 166
2. M. Andersen, K. Overgaard, P. Meden, G. Boysen, and S.C. Choi Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model Stroke 30 1999 1464 1471
3. M. Asahi, K. Asahi, X. Wang, and E.H. Lo Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats J. Cereb Blood Flow Metab. 20 2000 452 457
4. E. Banks, and K. Canfell Invited commentary: hormone therapy risks and benefits - the Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis Am. J. Epidemiol 170 2009 24 28
5. E. Barrett-Connor Hormones and heart disease in women: the timing hypothesis Am J. Epidemiol 166 2007 506 510
6. J. Bishop, and J.W. Simpkins Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro Mol. Cell Neurosci 5 1994 303 308
7. C. Bonithon-Kopp, X. Jouven, A. Taquet, P.J. Touboul, L. Guize, and P.Y. Scarabin Early carotid atherosclerosis in healthy middle-aged women. A follow-up study Stroke 24 1993 1837 1843
8. M.P. Bowes, R. Rothlein, S.C. Fagan, and J.A. Zivin Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy Neurology 45 1995 815 819
9. H.E. Brussaard, J.A. Leuven, H.M. Krans, and C. Kluft The effect of 17 beta-oestradiol on variables of coagulation and fibrinolysis in postmenopausal women with type 2 diabetes mellitus Vascul. Pharmacol 39 2002 141 147
10. H.V. Carswell, N.H. Anderson, J.J. Morton, J. McCulloch, A.F. Dominiczak, and I.M. Macrae Investigation of estrogen status and increased stroke sensitivity on cerebral blood flow after a focal ischemic insult J. Cereb. Blood Flow Metab. 20 2000 931 936
11. H.V. Carswell, D. Bingham, K. Wallace, M. Nilsen, D.I. Graham, A.F. Dominiczak, and I.M. Macrae Differential effects of 17beta-estradiol upon stroke damage in stroke prone and normotensive rats J. Cereb. Blood Flow Metab. 24 2004 298 304
12. J. Chen, W. Xu, and H. Jiang 17 beta-estradiol protects neurons from ischemic damage and attenuates accumulation of extracellular excitatory amino acids Anesth. Analg. 92 2001 1520 1523
13. M.J. Cipolla, A.L. McCall, N. Lessov, and J.M. Porter Reperfusion decreases myogenic reactivity and alters middle cerebral artery function after focal cerebral ischemia in rats Stroke 28 1997 176 180
14. M.J. Cipolla, and A.B. Curry Middle cerebral artery function after stroke: the threshold duration of reperfusion for myogenic activity Stroke 33 2002 2094 2099
15. L.H. Coker, M.A. Espeland, S.R. Rapp, C. Legault, S.M. Resnick, P. Hogan, S. Gaussoin, M. Dailey, and S.A. Shumaker Postmenopausal hormone therapy and cognitive outcomes: the Women's Health Initiative Memory Study (WHIMS) J. Steroid Biochem. Mol. Biol. 118 2010 304 310
16. C. Culmsee, H. Vedder, A. Ravati, V. Junker, D. Otto, B. Ahlemeyer, J.C. Krieg, and J. Krieglstein Neuroprotection by estrogens in a mouse model of focal cerebral ischemia and in cultured neurons: evidence for a receptor-independent antioxidative mechanism J. Cereb. Blood Flow Metab. 19 1999 1263 1269
17. R.E. De Meersman, A.S. Zion, E.G. Giardina, J.P. Weir, J.S. Lieberman, and J.A. Downey Estrogen replacement, vascular distensibility, and blood pressures in postmenopausal women Am. J. Physiol. 274 1998 H1539 H1544
18. G.J. Del Zoppo Toward the neurovascular unit a journey in clinical translation: 2012 thomas willis lecture Stroke 44 2013 263 269
19. D.B. Dubal, M.L. Kashon, L.C. Pettigrew, J.M. Ren, S.P. Finklestein, S.W. Rau, and P.M. Wise Estradiol protects against ischemic injury J. Cereb. Blood Flow Metab. 18 1998 1253 1258
20. E.A. Doisy, C.D. Veler, and S. Thayer The presentation of the crystalline ovarian hormone from the urine of pregnant women J. Biol. Chem. 86 1930 499 509
21. M.A. Espeland, S.R. Rapp, S.A. Shumaker, R. Brunner, J.E. Manson, B.B. Sherwin, J. Hsia, K.L. Margolis, P.E. Hogan, R. Wallace, M. Dailey, R. Freeman, and J. Hays Conjugated equine estrogens and global cognitive function in postmenopausal women: women's Health Initiative Memory Study J. Am. Med. Assoc. 291 2004 2959 2968
22. R.T. Frank, F.M. Gustavson, and R.G. Weyerts WW. Demonstration of the female sex hormone in the circulating blood. I. prelininary report J. Am. Med. Assoc. 85 1925 510
23. K. Fukuda, H. Yao, S. Ibayashi, T. Nakahara, H. Uchimura, M. Fujishima, and E.D. Hall Ovariectomy exacerbates and estrogen replacement attenuates photothrombotic focal ischemic brain injury in rats Stroke 31 2000 155 160
24. L.M. Garcia-Segura, F. Naftolin, J.B. Hutchison, I. Azcoitia, and J.A. Chowen Role of astroglia in estrogen regulation of synaptic plasticity and brain repair J. Neurobiol. 40 1999 574 584
25. G.G. Geary, D.N. Krause, and S.P. Duckles Estrogen reduces myogenic tone through a nitric oxide-dependent mechanism in rat cerebral arteries Am. J. Physiol. 275 1998 H292 H300
26. R.F. Gillum New considerations in analyzing stroke and heart disease mortality trends: the Year 2000 Age Standard and the International Statistical Classification of Diseases and Related Health Problems, 10th Revision Stroke 33 2002 1717 1721
27. J. Grotta Combination therapy stroke trial. rt-PA +/- lubeluzole Ann. N.Y. Acad. Sci. 939 2001 309 310
28. W. Hacke, G. Donnan, C. Fieschi, M. Kaste, R. von Kummer, J.P. Broderick, T. Brott, M. Frankel, J.C. Grotta, E.C. Haley Jr.; T. Kwiatkowski, S.R. Levine, C. Lewandowski, M. Lu, P. Lyden, J.R. Marler, S. Patel, B.C. Tilley, G. Albers, E. Bluhmki, M. Wilhelm, and S. Hamilton Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials Lancet 363 2004 768 774
29. E.D. Hall, K.E. Pazara, and K.L. Linseman Sex differences in postischemic neuronal necrosis in gerbils J. Cereb. Blood Flow Metab. 11 1991 292 298
30. I. Harukuni, P.D. Hurn, and B.J. Crain Deleterious effect of beta-estradiol in a rat model of transient forebrain ischemia Brain Res. 900 2001 137 142
31. T. Hawk, Y.Q. Zhang, G. Rajakumar, A.L. Day, and J.W. Simpkins Testosterone increases and estradiol decreases middle cerebral artery occlusion lesion size in male rats Brain Res. 796 1998 296 298
32. S.L. Hendrix, S. Wassertheil-Smoller, K.C. Johnson, B.V. Howard, C. Kooperberg, J.E. Rossouw, M. Trevisan, A. Aragaki, A.E. Baird, P.F. Bray, J.E. Buring, M.H. Criqui, D. Herrington, J.K. Lynch, S.R. Rapp, and J. Torner Effects of conjugated equine estrogen on stroke in the Women's health initiative Circulation 113 2006 2425 2434
33. F. Jimenez-Altayo, A. Martin, S. Rojas, C. Justicia, A.M. Briones, J. Giraldo, A.M. Planas, and E. Vila Transient middle cerebral artery occlusion causes different structural, mechanical, and myogenic alterations in normotensive and hypertensive rats Am. J. Physiol. Heart Circ. Physiol. 293 2007 H628 H635
34. K.K. Koh, and I. Sakuma Should progestins be blamed for the failure of hormone replacement therapy to reduce cardiovascular events in randomized controlled trials? Arterioscler. Thromb. Vasc. Biol. 24 2004 1171 1179
35. R.L. Leon, X. Li, J.D. Huber, and C.L. Rosen Worsened outcome from middle cerebral artery occlusion in aged rats receiving 17beta-estradiol Endocrinology 153 2012 3386 3393
36. R. Liu, Y. Wen, E. Perez, X. Wang, A.L. Day, J.W. Simpkins, and S.H. Yang 17beta-Estradiol attenuates blood-brain barrier disruption induced by cerebral ischemia-reperfusion injury in female rats Brain Res. 1060 2005 55 61
37. R. Liu, Q. Liu, S. He, J.W. Simpkins, and S.H. Yang Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke J. Pharmacol. Exp. Ther. 332 2010 1006 1012
38. E.H. Lo, J.P. Broderick, and M.A. Moskowitz tPA and proteolysis in the neurovascular unit Stroke 35 2004 354 356
39. P.D. Lyden, M. Lu, S.R. Levine, T.G. Brott, and J. Broderick A modified National Institutes of Health Stroke Scale for use in stroke clinical trials: preliminary reliability and validity Stroke 32 2001 1310 1317
40. P.M. Maki Hormone therapy and cognitive function: is there a critical period for benefit? Neuroscience 138 2006 1027 1030
41. L.D. McCullough, N.J. Alkayed, R.J. Traystman, M.J. Williams, and P.D. Hurn Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke Stroke 32 2001 796 802
42. L.D. McCullough, and P.D. Hurn Estrogen and ischemic neuroprotection: an integrated view Trends Endocrinol. Metab. 14 2003 228 235
43. P. Meden, K. Overgaard, T. Sereghy, and G. Boysen Enhancing the efficacy of thrombolysis by AMPA receptor blockade with NBQX in a rat embolic stroke model J. Neurol. Sci. 119 1993 209 216
44. A. Mendelowitsch, M.F. Ritz, J. Ros, H. Langemann, and O. Gratzl 17beta-Estradiol reduces cortical lesion size in the glutamate excitotoxicity model by enhancing extracellular lactate: a new neuroprotective pathway Brain Res. 901 2001 230 236
45. G. Mor, J. Nilsen, T. Horvath, I. Bechmann, S. Brown, L.M. Garcia-Segura, and F. Naftolin Estrogen and microglia: a regulatory system that affects the brain J. Neurobiol. 40 1999 484 496
46. Y. Nagai, C.J. Earley, M.K. Kemper, C.S. Bacal, and E.J. Metter Influence of age and postmenopausal estrogen replacement therapy on carotid arterial stiffness in women Cardiovasc. Res. 41 1999 307 311
47. S. Penz, A.J. Reininger, R. Brandl, P. Goyal, T. Rabie, I. Bernlochner, E. Rother, C. Goetz, B. Engelmann, P.A. Smethurst, W.H. Ouwehand, R. Farndale, B. Nieswandt, and W. Siess Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI Faseb J. 19 2005 898 909
48. T. Pfefferkorn, and G.A. Rosenberg Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion Stroke 34 2003 2025 2030
49. R.L. Prentice, J.E. Manson, R.D. Langer, G.L. Anderson, M. Pettinger, R.D. Jackson, K.C. Johnson, L.H. Kuller, D.S. Lane, J. Wactawski-Wende, R. Brzyski, M. Allison, J. Ockene, G. Sarto, and J.E. Rossouw Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause Am. J. Epidemiol. 170 2009 12 23
50. W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S.M. Hailpern, M. Ho, V. Howard, B. Kissela, S. Kittner, D. Lloyd-Jones, M. McDermott, J. Meigs, C. Moy, G. Nichol, C. O'Donnell, V. Roger, P. Sorlie, J. Steinberger, T. Thom, M. Wilson, and Y. Hong Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 117 2008 e25 146
51. F.R. Rosendaal, M. Vessey, A. Rumley, E. Daly, M. Woodward, F.M. Helmerhorst, and G.D. Lowe Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis Br. J. Haematol. 116 2002 851 854
52. B. Schaller, and R. Graf Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy J. Cereb. Blood Flow Metab. 24 2004 351 371
53. E. Scott, Q.G. Zhang, R. Wang, R. Vadlamudi, and D. Brann Estrogen neuroprotection and the critical period hypothesis Front Neuroendocrinol. 33 2012 85 104
54. A. Selvamani, and F. Sohrabji The neurotoxic effects of estrogen on ischemic stroke in older female rats is associated with age-dependent loss of insulin-like growth factor-1 J. Neurosci. 30 2010 6852 6861
55. A. Selvamani, and F. Sohrabji Reproductive age modulates the impact of focal ischemia on the forebrain as well as the effects of estrogen treatment in female rats Neurobiol. Aging 31 2010 1618 1628
56. A. Selvamani, P. Sathyan, R.C. Miranda, and F. Sohrabji An antagomir to microRNA Let7f promotes neuroprotection in an ischemic stroke model PLoS One 7 2012 e32662
57. B.B. Sherwin Estrogen therapy: is time of initiation critical for neuroprotection? Nat. Rev. Endocrinol. 5 2009 620 627
58. J.A. Simon, J. Hsia, J.A. Cauley, C. Richards, F. Harris, J. Fong, E. Barrett-Connor, and S.B. Hulley Postmenopausal hormone therapy and risk of stroke: the Heart and Estrogen-progestin Replacement Study (HERS) Circulation 103 2001 638 642
59. J.W. Simpkins, G. Rajakumar, Y.Q. Zhang, C.E. Simpkins, D. Greenwald, C.J. Yu, N. Bodor, and A.L. Day Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat J. Neurosurg. 87 1997 724 730
60. P. Skarsgard, C. van Breemen, and I. Laher Estrogen regulates myogenic tone in pressurized cerebral arteries by enhanced basal release of nitric oxide Am. J. Physiol. 273 1997 H2248 H2256
61. Society The 2012 hormone therapy position statement of: the North American Menopause Society Menopause 19 2012 257 271
62. F. Sohrabji, A. Selvamani, and R. Balden Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke Horm. Behav. 2012
63. C. Stapf, and J.P. Mohr Ischemic stroke therapy Annu. Rev Med. 53 2002 453 475
64. S. Sudo, T.C. Wen, J. Desaki, S. Matsuda, J. Tanaka, T. Arai, N. Maeda, and M. Sakanaka Beta-estradiol protects hippocampal CA1 neurons against transient forebrain ischemia in gerbil Neurosci. Res. 29 1997 345 354
65. T. Sumii, and E.H. Lo Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats Stroke 33 2002 831 836
66. T. Takao, N. Flint, L. Lee, X. Ying, J. Merrill, and K.J. Chandross 17beta-estradiol protects oligodendrocytes from cytotoxicity induced cell death J. Neurochem. 89 2004 660 673
67. T.J. Toung, R.J. Traystman, and P.D. Hurn Estrogen-mediated neuroprotection after experimental stroke in male rats Stroke 29 1998 1666 1670
68. T.K. Toung, P.D. Hurn, R.J. Traystman, and F.E. Sieber Estrogen decreases infarct size after temporary focal ischemia in a genetic model of type 1 diabetes mellitus Stroke 31 2000 2701 2706
69. L.C. Turtzo, and L.D. McCullough Sex differences in stroke Cerebrovasc. Dis. 26 2008 462 474
70. C.M. Viscoli, L.M. Brass, W.N. Kernan, P.M. Sarrel, S. Suissa, and R.I. Horwitz A clinical trial of estrogen-replacement therapy after ischemic stroke N. Engl. J. Med. 345 2001 1243 1249
71. J.M. Wardlaw, P.A. Sandercock, and E. Berge Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis Stroke 34 2003 1437 1442
72. S. Wassertheil-Smoller, S.L. Hendrix, M. Limacher, G. Heiss, C. Kooperberg, A. Baird, T. Kotchen, J.D. Curb, H. Black, J.E. Rossouw, A. Aragaki, M. Safford, E. Stein, S. Laowattana, and W.J. Mysiw Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial J. Am. Med. Assoc. 289 2003 2673 2684
73. A. Winters, J.C. Taylor, M. Ren, R. Ma, R. Liu, and S.H. Yang Transient focal cerebral ischemia induces long-term cerebral vasculature dysfunction in a rodent experimental stroke model Transl. Stroke Res. 3 2012 279 285
74. P.M. Wise, D.B. Dubal, M.E. Wilson, S.W. Rau, M. Bottner, and K.L. Rosewell Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies Brain Res. Brain Res. Rev. 37 2001 313 319
75. S.H. Yang, J. Shi, A.L. Day, and J.W. Simpkins Estradiol exerts neuroprotective effects when administered after ischemic insult Stroke 31 2000 745 749 discussion 749-50
76. S.H. Yang, Z. He, S.S. Wu, Y.J. He, J. Cutright, W.J. Millard, A.L. Day, and J.W. Simpkins 17-beta estradiol can reduce secondary ischemic damage and mortality of subarachnoid hemorrhage J. Cereb. Blood Flow Metab. 21 2001 174 181
77. S.H. Yang, R. Liu, S.S. Wu, and J.W. Simpkins The use of estrogens and related compounds in the treatment of damage from cerebral ischemia Ann. N.Y. Acad. Sci. 1007 2003 101 107
78. S.H. Yang, R. Liu, E.J. Perez, X. Wang, and J.W. Simpkins Estrogens as protectants of the neurovascular unit against ischemic stroke Curr. Drug Targets CNS Neurol. Disord 4 2005 169 177
79. Y. Yang, Q. Li, and A. Shuaib Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate Neuropharmacology 39 2000 881 888
80. J.H. Zhang, J. Badaut, J. Tang, A. Obenaus, R. Hartman, and W.J. Pearce The vascular neural network - a new paradigm in stroke pathophysiology Nat. Rev. Neurol. 8 2012 711 716
81. J.A. Zivin, and V. Mazzarella Tissue plasminogen activator plus glutamate antagonist improves outcome after embolic stroke Arch. Neurol. 48 1991 1235 1238
82. J.A. Zivin Thrombolytic stroke therapy: past, present, and future Neurology 53 1999 14 19
83. M.A. de Lecinana, J.A. Egido, C. Fernandez, E. Martinez-Vila, S. Santos, A. Morales, E. Martinez, A. Pareja, J. Alvarez-Sabin, and I. Casado Risk of ischemic stroke and lifetime estrogen exposure Neurology 68 2007 33 38